Get started Log in

ZYME — Zymeworks News Story

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Market Cap
$2.03bn
Enterprise Value
$2.02bn
Revenue
$105.97m

Zymeworks strikes $929 million deal for Theravance Biopharma

29/06/2026 11:04

Zymeworks strikes $929 million deal for Theravance BiopharmaJune 29 (Reuters) - Drugmaker Zymeworks ZYME.O said on Monday it will buy Theravance Biopharma TBPH.O in a $929 million deal. 

(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Jonathan Ananda)
((Padmanabhan.Ananthan@thomsonreuters.com;))

Recent news on Zymeworks

US STOCKS ON THE MOVE-Huron Consulting, RingCentral, Selective Insurance
Yesterday 18:42
U.S. STOCKS ON THE MOVE-Huron Consulting, Crown Castle, Bloom Energy
Yesterday 16:41
US STOCKS ON THE MOVE-Booz Allen Hamilton, SLB, Deckers Outdoor
Yesterday 14:03
US STOCKS ON THE MOVE-American Express, Gorman-Rupp, Moderna
Yesterday 12:35
Zymeworks gains on up to $813 million Roche licensing deal for lung cancer drug
Yesterday 12:18